A carregar...

Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells

Increased evidence suggests that somatic mutations in the ligand-binding domain of estrogen receptor [ER (ERα/ESR1)] are critical mediators of endocrine-resistant breast cancer progression. Insulinlike growth factor-1 (IGF1) is an essential regulator of breast development and tumorigenesis and also...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinology
Main Authors: Li, Zheqi, Levine, Kevin M., Bahreini, Amir, Wang, Peilu, Chu, David, Park, Ben Ho, Oesterreich, Steffi, Lee, Adrian V.
Formato: Artigo
Idioma:Inglês
Publicado em: Endocrine Society 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5761602/
https://ncbi.nlm.nih.gov/pubmed/29029116
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2017-00693
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!